Oral Contraceptive Pills as Primary Prevention for Ovarian Cancer: A Systematic Review and Meta-analysis

@article{Havrilesky2013OralCP,
  title={Oral Contraceptive Pills as Primary Prevention for Ovarian Cancer: A Systematic Review and Meta-analysis},
  author={L. Havrilesky and P. Moorman and W. Lowery and Jennifer M. Gierisch and R. Coeytaux and R. Urrutia and M. Dinan and Amanda J McBroom and V. Hasselblad and G. Sanders and E. Myers},
  journal={Obstetrics & Gynecology},
  year={2013},
  volume={122},
  pages={139–147}
}
  • L. Havrilesky, P. Moorman, +8 authors E. Myers
  • Published 2013
  • Medicine
  • Obstetrics & Gynecology
    • OBJECTIVE: To estimate the overall reduction in ovarian cancer risk associated with the use of oral contraceptive pills (OCPs) and whether reduction in risk is affected by specifics of OCP use, such as formulation or duration of use. DATA SOURCES: We searched PubMed, Embase, the Cochrane Database of Systematic Reviews, and ClinicalTrials.gov for studies published from January 1990 to June 2012, with primary analysis of studies published since January 2000. METHODS OF STUDY SELECTION: We… CONTINUE READING
    View on Wolters Kluwer
    drzielke.com
    Top 3 of 48 Citations
    Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis.
    Ioannis Hatzipetros, P. Gőcze, B. FarkasObstetrics and gynecology2013
    87
    Cancer incidence attributable to the use of oral contraceptives and hormone therapy in Alberta in 2012.
    Xin Grevers, A. Grundy, … D. BrennerCMAJ open2016
    9
    European Code against Cancer 4th Edition: Medical exposures, including hormone therapy, and cancer.
    S. Friis, A. Kesminiene, … J. SchüzCancer epidemiology2015
    32
    48 Citations
    Citation Type

    Citation Type

    Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis.
    • 87
    Cancer incidence attributable to the use of oral contraceptives and hormone therapy in Alberta in 2012.
    • 9
    • PDF
    European Code against Cancer 4th Edition: Medical exposures, including hormone therapy, and cancer.
    • 32
    • PDF
    The Chemoprevention of Ovarian Cancer: the Need and the Options
    • 4
    • PDF
    Interventions to reduce the risk of ovarian and fallopian tube cancer: A European Menopause and Andropause Society Postition Statement.
    • 9
    Long and irregular menstrual cycles, polycystic ovary syndrome, and ovarian cancer risk in a population‐based case‐control study
    • 27
    Screening and Prevention of Ovarian Cancer
    Breastfeeding factors and risk of epithelial ovarian cancer.
    • 6
    • PDF
    The combined oral contraceptive pill -- recent developments, risks and benefits.
    • 33
    Menopausal hormone therapy in cancer survivors: A narrative review of the literature.
    • 17

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 30 REFERENCES
    Oral contraceptive use for the primary prevention of ovarian cancer.
    • 46
    • PDF
    Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls.
    • 511
    • PDF
    Long‐term effects of oral contraceptives on ovarian cancer risk
    • 110
    Pooled analysis of 3 european case‐control studies of epithelial ovarian cancer: III. Oral contraceptive use
    • 156
    Ovarian cancer and hormone replacement therapy in the Million Women Study
    • 792
    • PDF
    Prospective study of oral contraceptives and hypertension among women in the United States.
    • 260
    Screening for ovarian cancer: a pilot randomised controlled trial
    • 428
    Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.
    • 689
    • PDF
    Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
    • 715
    Screening for Ovarian Cancer: U.S. Preventive Services Task Force Reaffirmation Recommendation Statement
    • 213
    • PDF